SCHEMBL20907712

SCHEMBL20907712

C=C(C)CC(N)(C(=O)OC(C)C)c1ccc(Br)cc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
ALDH1A1 P00352 2/20 0.35
PTPN1 P18031 1/20 0.34
MAPT P10636 3/20 0.33
EPHX1 P07099 2/20 0.32
OGG1 O15527 1/20 0.32
KIF11 P52732 1/20 0.32
CYP1A2 P05177 2/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
ALOX5 P09917 1/20 0.31
GAA P10253 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
LMNA P02545 1/20 0.30
ALPL P05186 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20907565 0.81 KMT2A (0.40) MEN1KMT2AALDH1A1PTPN1MAPT
SCHEMBL20908058 0.81 KMT2A (0.40) MEN1KMT2AALDH1A1PTPN1MAPT
SCHEMBL20907785 0.78 PTPN1 (0.40) MEN1KMT2AALDH1A1PTPN1MAPT
SCHEMBL28890354 0.78 PTPN1 (0.40) MEN1KMT2AALDH1A1PTPN1MAPT
SCHEMBL20907818 0.77 CYP2D6 (0.38) MEN1KMT2AALDH1A1CYP2D6CYP2C9
SCHEMBL21148934 0.77 CYP2D6 (0.38) MEN1KMT2AALDH1A1CYP2D6CYP2C9
SCHEMBL22619411 0.76 PTPN1 (0.38) MEN1KMT2AALDH1A1PTPN1MAPT
SCHEMBL20899678 0.76 MEN1 (0.37) MEN1KMT2AALDH1A1PTPN1MAPT
SCHEMBL20907662 0.76 PTPN1 (0.38) MEN1KMT2AALDH1A1PTPN1MAPT
SCHEMBL30557222 0.74 BRD4 (0.35) MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019075291-A1 1-BENZYL-2-IMINO-4-PHENYL-5-OXOIMIDAZOLIDINE DERIVATIVES AS HIV PROTEASE INHIBITORS GILEAD SCIENCES, INC. (US) 2019-04-18 WO disclosed